Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare Biotechnology

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd > I miss all the old school investors from 2018

<< Previous

Bullboard Posts

Next >>

Comment by DavidRosenbergon Sep 11, 2021 10:36pm

50 Views

Post# 33845747

RE:RE:RE:RE:RE:RE:RE:I miss all the old school investors from 2018

It's very telling is one of the phrases the shortseller likes to use lol

listen for now stock price is tanked , waiting for lucid to close so they can rely on more then one drug compound AD mentioned this in the interview as a way to derisk

$ELYM has same drug as FSD, called PEA
Results due first half of 2022 as what they listed on their website if Negative results would be bad for FSD

if they get positive Results maybe will reinforce FSD 201 as a drug , it's dependant on which indication they want to target

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project